Cleveland, OH – According to filings with the U.S. Securities and Exchange Commission, S4 Medical is raising $2,200,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Fuller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About S4 Medical

S4 Medical is committed to developing solutions for safer and more effective catheter ablation treatment for atrial fibrillation.  S4’s esolution device is a patented technology intended to safely deviate and protect the esophagus. Designed by a team of physicians including electrophysiologists, cardiac anesthesiologists, and gastroenterologists, esolution is the only device that holds promise to protect the esophagus during catheter ablation.

To learn more about S4 Medical, visit http://s4medical.com/

Contact:
William Fuller, Chief Executive Officer
216-658-3999
bill@s4medical.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved